Last update 14 Dec 2024
Recombinant coagulation factor VIII (Rongsheng Pharmaceuticals)
Last update 14 Dec 2024
Overview
Basic Info
Drug Type Recombinant coagulation factor |
Synonyms- |
Target |
Mechanism F10 stimulants(Coagulation factor X stimulants), Blood coagulation pathway activation, Coagulation factor VIII replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (05 Sep 2023), |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with Recombinant coagulation factor VIII (Rongsheng Pharmaceuticals)评价人凝血因子Ⅷ在治疗血友病A患者中的安全性和有效性的上市后临床研究
[Translation] A post-marketing clinical study to evaluate the safety and efficacy of human coagulation factor VIII in the treatment of patients with hemophilia A
比较注射用重组人凝血因子Ⅷ和任捷用于经治疗成人及青少年重型血友病A患者中药代动力学特征的随机、开放、交叉设计、多中心临床试验
[Translation] A randomized, open, crossover, multicenter clinical trial comparing the pharmacokinetic characteristics of recombinant human coagulation factor VIII for injection and Renjie in treated adults and adolescents with severe hemophilia A
评价重组人凝血因子Ⅷ在经治疗儿童重型血友病A患者中预防治疗的有效性和安全性及药代动力学特征的单臂、开放、多中心临床试验
[Translation] A single-arm, open-label, multicenter clinical trial to evaluate the efficacy, safety, and pharmacokinetic characteristics of recombinant human coagulation factor VIII in the prevention and treatment of severe hemophilia A in children who have been treated
100 Clinical Results associated with Recombinant coagulation factor VIII (Rongsheng Pharmaceuticals)
Login to view more data
100 Translational Medicine associated with Recombinant coagulation factor VIII (Rongsheng Pharmaceuticals)
Login to view more data
100 Patents (Medical) associated with Recombinant coagulation factor VIII (Rongsheng Pharmaceuticals)
Login to view more data
1
Literatures (Medical) associated with Recombinant coagulation factor VIII (Rongsheng Pharmaceuticals)Postepy biochemii
Terapia genowa hemofilii – czy wkrótce będzie możliwe wyleczenie?
Review
Author: Kaczmarek, Radosław
100 Deals associated with Recombinant coagulation factor VIII (Rongsheng Pharmaceuticals)
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hemophilia A | CN | 05 Sep 2023 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| 6-Pyruvoyl-Tetrahydropterin Synthase Deficiency | Phase 1 | CN | 16 Jul 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free